The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.60
Bid: 67.20
Ask: 68.20
Change: -0.60 (-0.88%)
Spread: 1.00 (1.488%)
Open: 69.80
High: 69.80
Low: 67.60
Prev. Close: 68.20
SFR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 Oct 2014 16:01

RNS Number : 6379V
Severfield PLC
29 October 2014
 



 

TR-1: Notifications of Major Interests in Shares

 

1: Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Severfield PLC

 

 

2: Reason for notification (yes/no)

An acquisition or disposal of voting rights

yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

no

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

no

An event changing the breakdown of voting rights

no

Other (please specify):

 

no

 

3. Full name of person(s) subject to the notification

obligation:

Standard Life Investments (Holdings) Limited (Parent Company) -8.992% comprised of:

Standard Life Investments Limited - 8.159%

Ignis Investment Services Limited -0.834%

4. Full name of shareholder(s) (if different from 3.):

 Vidacos Nominees\HSBC

5. Date of the transaction (and date on which the threshold

is crossed or reached):

28/10/2014

6. Date on which issuer notified:

29/10/2014

7. Threshold(s) that is/are crossed or reached:

9%

8: Notified Details

A: Voting rights attached to shares

Class/type of share If possible use ISIN code

GB00B27YGJ97

 

 

Situation previous to the triggering transaction

Number of shares

Number of voting rights

26,929,221

 

26,929,221

 

 

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Percentage ofvoting rights

Direct

Indirect

Direct

Indirect

26,751,775

 

17,036,938

 

9,714,837

 

5.727

 

3.265

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired(if the instrument exercised/converted)

Percentage of voting rights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

26,751,775

 

8.992

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Standard Life Investments (Holdings) Limited (Parent Company) -8.992% comprised of:

Standard Life Investments Limited -8.159%

Ignis Investment Services Limited -0.834%

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

GIOS@standardlife.comStandard Life Investments Ltd

15. Contact telephone number:

 

(0131) 245 6565

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEKLFLZBFZFBK
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:14 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSChairman appointment
17th Apr 20247:00 amRNSTrading Statement
15th Apr 20247:53 amRNSProgressive publish new research
21st Mar 20245:35 pmRNSPDMR Shareholding
19th Feb 20241:58 pmRNSStandard form for notification of major holdings
8th Feb 20247:00 amRNSCDP ‘A List’ for climate change
18th Dec 20231:43 pmRNSDirector/PDMR Shareholding
21st Nov 20238:02 amRNSProgressive publishes new research
21st Nov 20237:00 amRNSInterim Results
6th Nov 20237:00 amRNSNotice of Investor Presentation
9th Oct 20232:46 pmRNSNotification of Transactions of Directors
18th Sep 20234:08 pmRNSRSP grant
6th Sep 20238:54 amRNSProgressive publishes new research
6th Sep 20237:00 amRNSAGM trading update
7th Aug 202312:12 pmRNSNotice of Annual General Meeting and Annual Report
31st Jul 20233:18 pmRNSDirector/PDMR Shareholding
31st Jul 20231:18 pmRNSDirectorate Change
26th Jul 20237:00 amRNSDirectorate Change
14th Jun 20237:00 amRNSNotice of Results and Investor Presentation
14th Jun 20237:00 amRNSFinal Results
18th May 202311:13 amRNSTotal Voting Rights
28th Apr 20237:35 amRNSProgressive publishes Spotlight note
3rd Apr 20232:11 pmRNSCompletion of Acquisition
27th Mar 20237:00 amRNSTrading Statement
21st Mar 202311:03 amRNSNotification of Major Holdings
16th Mar 202312:18 pmRNSProgressive publishes new research
15th Mar 20237:00 amRNSAcquisition
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.